A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study)

NCT04705259 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-10-14

No results posted yet for this study

Summary

The antimicrobial stewardship ENGAGEMENT study aims to deliver a bundle of interventions, including education of GPs and nursing staff, guideline implementation and telehealth support for 18 residential aged care facilities (RACFs) in Queensland Australia to help optimise antibiotic prescribing and reduce inappropriate use. The trial will involve 18 licenced RACFs with 50 or more residents and is set to commence in June 2021.

Conditions

  • Antimicrobial Stewardship
  • Antibiotics Causing Adverse Effects in Therapeutic Use

Interventions

BEHAVIORAL

Antimicrobial Stewardship ENGAGEMENT bundle

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs \[7\], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions: * Education and engagement of prescribers, nurses, pharmacists and residents and family members * Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing * Guideline development specific to antibiotic use in RACF residents * Antimicrobial stewardship team creation in RACF with GP involvement * EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum * ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing * Telehealth support for key intervention components

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER
  • The University of Queensland

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-05-30
Completion
2022-12-24

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04705259 on ClinicalTrials.gov